Ranalli Tamara A. 4

Accession 0000899243-22-020415

CIK 0000353569other

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 4:29 PM ET

Size

45.3 KB

Accession

0000899243-22-020415

Insider Transaction Report

Form 4

Period: 2022-05-27

QUIDEL CORP /DE/QDEL

Ranalli Tamara A.

SVP, Molecular Bus. Unit

Transactions

Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−4,957→ 0 total
Exercise: $103.36Exp: 2032-01-31→ Common Stock (4,957 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−3,194→ 0 total
Exercise: $22.21Exp: 2023-02-25→ Common Stock (3,194 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−2,372→ 0 total
Exercise: $77.16Exp: 2030-02-03→ Common Stock (2,372 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−1,906→ 0 total
Exercise: $228.21Exp: 2030-08-24→ Common Stock (1,906 underlying)
Disposition to Issuer
Common Stock
2022-05-27−15,486→ 0 total
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−3,910→ 0 total
Exercise: $23.41Exp: 2025-02-05→ Common Stock (3,910 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−3,020→ 0 total
Exercise: $59.12Exp: 2029-02-04→ Common Stock (3,020 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−6,360→ 0 total
Exercise: $27.57Exp: 2024-02-24→ Common Stock (6,360 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−1,954→ 0 total
Exercise: $15.40Exp: 2026-02-10→ Common Stock (1,954 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−1,892→ 0 total
Exercise: $254.00Exp: 2031-02-01→ Common Stock (1,892 underlying)
Disposition to Issuer
Restricted Stock Units
2022-05-27−1,510→ 0 total
→ Common Stock (1,510 underlying)
Disposition to Issuer
Restricted Stock Units
2022-05-27−591→ 0 total
→ Common Stock (591 underlying)
Disposition to Issuer
Restricted Stock Units
2022-05-27−1,420→ 0 total
→ Common Stock (1,420 underlying)
Disposition to Issuer
Restricted Stock Units
2022-05-27−1,186→ 0 total
→ Common Stock (1,186 underlying)
Disposition to Issuer
Restricted Stock Units
2022-05-27−4,958→ 0 total
→ Common Stock (4,958 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−1,349→ 0 total
Exercise: $21.08Exp: 2027-02-15→ Common Stock (1,349 underlying)
Disposition to Issuer
Non-Qualified Stock Options
2022-05-27−3,455→ 0 total
Exercise: $46.41Exp: 2028-01-16→ Common Stock (3,455 underlying)
Disposition to Issuer
Restricted Stock Units
2022-05-27−3,386→ 0 total
→ Common Stock (3,386 underlying)

Footnotes (16)

[F1]Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
[F10]Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
[F11]1,510 shares will vest on February 4, 2023.
[F12]1,186 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
[F13]591 shares will vest in equal installments on August 24, 2022, August 24, 2023 and August 24, 2024.
[F14]473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
[F15]1,239 shares will vest on each of January 31, 2023 and January 31, 2024; 1,240 shares will vest on each of January 31, 2025 and January 31, 2026.
[F16]1,693 shares will vest on January 31, 2024; 846 shares will vest on January 31, 2025; and 847 shares will vest on January 31, 2026.
[F2]Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
[F3]Vested in full.
[F4]2,265 shares are vested in full; 755 shares will vest on February 4, 2023.
[F5]1,186 shares are vested in full; the remaining 1,186 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
[F6]476 shares are vested in full; 476 shares will vest on August 24, 2022; the remaining 954 shares will vest in equal installments on August 24, 2023 and August 24, 2024.
[F7]473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
[F8]1,239 shares will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025;1,240 shares will vest on January 31, 2026.
[F9]Each restricted stock unit represents the right to receive one share of Quidel common stock.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

QUIDEL CORP /DE/

CIK 0000353569

→

Entity typeother

Related Parties

filerCIK 0001822508

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 4:29 PM ET
Size: 45.3 KB

View on SEC.gov